Literature DB >> 22777248

Correspondence: Measuring dystrophin-faster is not necessarily better.

Virginia Arechavala-Gomeza, Lucy Feng, Jennifer E Morgan, Francesco Muntoni.   

Abstract

Entities:  

Year:  2012        PMID： 22777248     DOI： 10.1038/nrneurol.2012.15-c1

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  15 in total

1.  185th ENMC International Workshop: stem/precursor cells as a therapeutic strategy for muscular dystrophies 3-5 June 2011, Naarden, The Netherlands.

Authors:  Ketan Patel; Jennifer Morgan
Journal:  Neuromuscul Disord       Date:  2011-11-29       Impact factor: 4.296

2.  Neuromuscular disease. A novel imaging method to quantify low levels of dystrophin in Duchenne muscular dystrophy.

Authors:  Katy Malpass
Journal:  Nat Rev Neurol       Date:  2012-02-07       Impact factor: 42.937

3.  Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens.

Authors:  L E Taylor; Y J Kaminoh; C K Rodesch; K M Flanigan
Journal:  Neuropathol Appl Neurobiol       Date:  2012-10       Impact factor: 8.090

4.  Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials.

Authors:  Virginia Arechavala-Gomeza; Maria Kinali; Lucy Feng; Michela Guglieri; Geraldine Edge; Marion Main; David Hunt; Jan Lehovsky; Volker Straub; Kate Bushby; Caroline A Sewry; Jennifer E Morgan; Francesco Muntoni
Journal:  Neuromuscul Disord       Date:  2010-04-14       Impact factor: 4.296

5.  Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials.

Authors:  Karen Anthony; Sebahattin Cirak; Silvia Torelli; Giorgio Tasca; Lucy Feng; Virginia Arechavala-Gomeza; Annarita Armaroli; Michela Guglieri; Chiara S Straathof; Jan J Verschuuren; Annemieke Aartsma-Rus; Paula Helderman-van den Enden; Katherine Bushby; Volker Straub; Caroline Sewry; Alessandra Ferlini; Enzo Ricci; Jennifer E Morgan; Francesco Muntoni
Journal:  Brain       Date:  2011-11-18       Impact factor: 13.501

6.  Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

Authors:  E P Hoffman; R H Brown; L M Kunkel
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

7.  Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.

Authors:  Vinod Malik; Louise R Rodino-Klapac; Laurence Viollet; Cheryl Wall; Wendy King; Roula Al-Dahhak; Sarah Lewis; Christopher J Shilling; Janaiah Kota; Carmen Serrano-Munuera; John Hayes; John D Mahan; Katherine J Campbell; Brenda Banwell; Majed Dasouki; Victoria Watts; Kumaraswamy Sivakumar; Ricardo Bien-Willner; Kevin M Flanigan; Zarife Sahenk; Richard J Barohn; Christopher M Walker; Jerry R Mendell
Journal:  Ann Neurol       Date:  2010-06       Impact factor: 10.422

8.  Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.

Authors:  Sebahattin Cirak; Virginia Arechavala-Gomeza; Michela Guglieri; Lucy Feng; Silvia Torelli; Karen Anthony; Stephen Abbs; Maria Elena Garralda; John Bourke; Dominic J Wells; George Dickson; Matthew J A Wood; Steve D Wilton; Volker Straub; Ryszard Kole; Stephen B Shrewsbury; Caroline Sewry; Jennifer E Morgan; Kate Bushby; Francesco Muntoni
Journal:  Lancet       Date:  2011-07-23       Impact factor: 79.321

9.  Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice.

Authors:  Alberto Malerba; Paul S Sharp; Ian R Graham; Virginia Arechavala-Gomeza; Keith Foster; Francesco Muntoni; Dominic J Wells; George Dickson
Journal:  Mol Ther       Date:  2010-11-23       Impact factor: 11.454

10.  Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study.

Authors:  Maria Kinali; Virginia Arechavala-Gomeza; Lucy Feng; Sebahattin Cirak; David Hunt; Carl Adkin; Michela Guglieri; Emma Ashton; Stephen Abbs; Petros Nihoyannopoulos; Maria Elena Garralda; Mary Rutherford; Caroline McCulley; Linda Popplewell; Ian R Graham; George Dickson; Matthew J A Wood; Dominic J Wells; Steve D Wilton; Ryszard Kole; Volker Straub; Kate Bushby; Caroline Sewry; Jennifer E Morgan; Francesco Muntoni
Journal:  Lancet Neurol       Date:  2009-08-25       Impact factor: 44.182
View more
  1 in total

1.  Dystrophin quantification: Biological and translational research implications.

Authors:  Karen Anthony; Virginia Arechavala-Gomeza; Laura E Taylor; Adeline Vulin; Yuuki Kaminoh; Silvia Torelli; Lucy Feng; Narinder Janghra; Gisèle Bonne; Maud Beuvin; Rita Barresi; Matt Henderson; Steven Laval; Afrodite Lourbakos; Giles Campion; Volker Straub; Thomas Voit; Caroline A Sewry; Jennifer E Morgan; Kevin M Flanigan; Francesco Muntoni
Journal:  Neurology       Date:  2014-10-29       Impact factor: 9.910
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.